Showing results (241-250 of 427) with videos related to

Sort By:
Pageof 43
Leukemia & Lymphoma|September 15, 2021
Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI)Paola Guglielmelli, Francesca Palandri, Carmine Selleri, et al.
Annals of Hematology|October 22, 2024
Health-related quality of life benefits of arsenic trioxide in patients with non-high-risk acute promyelocytic leukemia are sustained over time: long-term results of the GIMEMA APL0406 trialFabio Efficace, Francesco Sparano, Massimo Breccia, et al.
British Journal of Haematology|August 19, 2020
Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parametersCarmelo Gurnari, Massimo Breccia, Francesca Di Giuliano, et al.
Haematologica|September 14, 2019
Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolismLuca Mazzarella, Edoardo Botteri, Anthony Matthews, et al.
Annals of Hematology|June 28, 2018
Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemiaLuca Maurillo, Francesco Buccisano, Alessandra Spagnoli, et al.
Annals of Hematology|March 23, 2022
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial groupSara Pepe, Elena Rossi, Malgorzata Trawinska, et al.
The Oncologist|May 25, 2026
Add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: a randomized phase 3 studyJean-Jacques Kiladjian, Uma Borate, Elisabetta Abruzzese, et al.
Haematologica|March 28, 2008
Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcomeFrancesca Palandri, Ilaria Iacobucci, Fausto Castagnetti, et al.
Acta Haematologica|March 18, 2011
Management of the 2009 A/H1N1 influenza pandemic in patients with hematologic diseases: a prospective experience at an Italian centerCorrado Girmenia, Caterina Mercanti, Vincenzo Federico, et al.
Annals of Hematology|December 14, 2019
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practiceMassimo Breccia, Claudia Baratè, Giulia Benevolo, et al.
Pageof 43